Periciazine
![]() |
|
Systematic (IUPAC) name | |
---|---|
10-[3-(4-hydroxypiperidin-1-yl)propyl]-10H-phenothiazine-2-carbonitrile
|
|
Clinical data | |
Pregnancy category |
|
Legal status | |
Routes of administration |
Oral |
Pharmacokinetic data | |
Metabolism | Hepatic (mostly via conjugation)[1] |
Biological half-life | 12 h[1] |
Excretion | Renal[1] |
Identifiers | |
CAS Number | 2622-26-6 ![]() |
ATC code | N05AC01 (WHO) |
PubChem | CID: 4747 |
DrugBank | DB01608 ![]() |
ChemSpider | 4585 ![]() |
UNII | 3405M6FD73 ![]() |
KEGG | D01485 ![]() |
ChEBI | CHEBI:31981 ![]() |
ChEMBL | CHEMBL251940 ![]() |
Chemical data | |
Formula | C21H23N3OS |
Molecular mass | 365.49 g/mol |
|
|
|
|
![]() ![]() |
Periciazine (INN), also known as pericyazine (BAN) or propericiazine, is a drug that belongs to the phenothiazine class of typical antipsychotics.
Pericyazine is not approved for sale in the United States. It is commonly sold in Canada under the tradename Neuleptil and in United Kingdom and Australia under the tradename Neulactil.[2]
Medical Uses
The primary uses of pericyazine include in the short-term treatment of severe anxiety or tension and in the maintenance treatment of psychotic disorders such as schizophrenia. There is insufficient evidence to determine whether periciazine is more or less effective than other antipsychotics.[1][3]
Periciazine has also been studied in the treatment of opioid dependence.[4]
Adverse effects
Pericyazine is a rather sedating and anticholinergic antipsychotic, and despite being classed with the typical antipsychotics, its risk of extrapyramidal side effects is comparatively low.[5] It has a relatively high risk of causing hyperprolactinaemia and a moderate risk of causing weight gain and orthostatic hypotension.[5]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- Neulactil - Summary of Product Characteristics from the electronic Medicines Compendium
- [1] from the Therapeutic Goods Administration.
- [2] from Health Canada.
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
Receptor (ligands) |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Transporter (inhibitors) |
|
||||||||
Enzyme (inhibitors) |
|
||||||||
Others |
|
||||||||
|
Classes | |
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
<templatestyles src="Asbox/styles.css"></templatestyles>
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- ↑ 1.0 1.1 1.2 1.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Leucht S, Helfer B, Hartung B. Perazine for schizophrenia. Cochrane Database Syst Rev. 2014 Jan 15;1:CD002832. Review. doi:10.1002/14651858.CD002832.pub3 PMID 24425538
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 5.0 5.1 Lua error in package.lua at line 80: module 'strict' not found.
- Pages with reference errors
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Typical antipsychotics
- Phenothiazines
- Piperidines
- Nitriles
- Alcohols
- Nervous system drug stubs